These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8395153)

  • 21. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
    Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
    Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
    N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels.
    Hewett SJ; Atchison WD
    Brain Res; 1992 Dec; 599(2):324-32. PubMed ID: 1363289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional evaluation of inhibition of autonomic transmitter release by autoantibody from Lambert-Eaton myasthenic syndrome.
    Houzen H; Hattori Y; Kanno M; Kikuchi S; Tashiro K; Motomura M; Nakao Y; Nakamura T
    Ann Neurol; 1998 May; 43(5):677-80. PubMed ID: 9585366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lambert-Eaton antibodies promote activity-dependent enhancement of exocytosis in bovine adrenal chromaffin cells.
    Engisch KL; Rich MM; Cook N; Nowycky MC
    Ann N Y Acad Sci; 1999 Apr; 868():213-6. PubMed ID: 10414296
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lambert-Eaton syndrome without calcium channel autoantibodies].
    Delpont E; Martin-Moutot N; Brunetto JL; Desnuelle C
    Rev Neurol (Paris); 1994; 150(3):244-7. PubMed ID: 7863174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
    Lang B; Pinto A; Giovannini F; Newsom-Davis J; Vincent A
    Ann N Y Acad Sci; 2003 Sep; 998():187-95. PubMed ID: 14592874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of autoantibodies in Lambert-Eaton myasthenic syndrome.
    Lang B; Waterman S; Pinto A; Jones D; Moss F; Boot J; Brust P; Williams M; Stauderman K; Harpold M; Motomura M; Moll JW; Vincent A; Newsom-Davis J
    Ann N Y Acad Sci; 1998 May; 841():596-605. PubMed ID: 9668304
    [No Abstract]   [Full Text] [Related]  

  • 29. Disruption of synaptosomal calcium channel function by Lambert-Eaton myasthenic immunoglobulin is serum-dependent.
    Hewett SJ; Atchison WD
    Brain Res; 1992 Dec; 599(2):317-23. PubMed ID: 1363288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
    Johnston I; Lang B; Leys K; Newsom-Davis J
    Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium channel autoantibody and non-small-cell lung cancer in patients with Lambert-Eaton syndrome.
    Sher E; Comola M; Nemni R; Canal N; Clementi F
    Lancet; 1990 Feb; 335(8686):413. PubMed ID: 1968140
    [No Abstract]   [Full Text] [Related]  

  • 32. A case report of the efficient reduction of calcium channel antibodies by tryptophan ligand immunoadsorption in a patient with Lambert-Eaton syndrome.
    Sauter M; Bender A; Heller F; Sitter T
    Ther Apher Dial; 2010 Jun; 14(3):364-7. PubMed ID: 20609193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Lambert-Eaton syndrome.
    Smith RG; Appel SH
    Hosp Pract (Off Ed); 1992 Dec; 27(12):101-6, 111-3, 116. PubMed ID: 1333470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
    Waterman SA; Lang B; Newsom-Davis J
    Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 1) The molecular structure of calcium channel and immunology].
    Komai K; Iwasa K; Takamori M
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):678-84. PubMed ID: 9627477
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibodies against calcium channels in the Lambert-Eaton myasthenic syndrome.
    Wray DW; Lang B; Newsom-Davis J; Peers C
    Ann N Y Acad Sci; 1989; 560():269-77. PubMed ID: 2545139
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anti-voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome].
    Motomura M; Suenaga A; Matsuo H; Tsujihata M; Nagataki S
    Rinsho Shinkeigaku; 1994 Oct; 34(10):980-4. PubMed ID: 7834958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymptomatic Lambert-Eaton syndrome.
    Denys EH; Lennon VA
    Muscle Nerve; 2014 May; 49(5):764-7. PubMed ID: 24259319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
    Bain PG; Motomura M; Newsom-Davis J; Misbah SA; Chapel HM; Lee ML; Vincent A; Lang B
    Neurology; 1996 Sep; 47(3):678-83. PubMed ID: 8797464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium channel types at the neuromuscular junction.
    Wray D; Porter V
    Ann N Y Acad Sci; 1993 Jun; 681():356-67. PubMed ID: 8395150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.